文献速递食管与纵隔外科

食管腺癌新辅助放化疗及R0切除后淋巴结转移的模式与影响

Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-03-01

本研究纳入2010至2018年在本机构接受新辅助放化疗及R0食管切除术的537例食管腺癌患者,评估淋巴结转移部位与无病生存的关联。结果显示36%的患者存在病理淋巴结转移,阳性淋巴结站数增加(HR 1.59,95%CI 1.35-1.84,P<.01)、特别是隆突下(HR 2.78,95%CI 1.54-5.03,P<.01)和食管旁站(HR 2.0,95%CI 1.58-2.54,P<.01)与复发风险增加相关。

要点

  • 537例中193例(36%)术后病理证实淋巴结转移,153例(28%)为单站,32例(6.0%)为两站,8例(1.5%)为三站。
  • 多站阳性患者中,食管旁站阳性占93%,左胃站阳性占60%。
  • 阳性淋巴结站数增加与复发风险增加相关(HR 1.59,95%CI 1.35-1.84,P<.01)。

核心结论

  • 接受诱导放化疗后R0切除的食管腺癌患者中约三分之一存在转移淋巴结,阳性淋巴结站数增加、特别是食管旁和隆突下转移与复发风险增加相关。

研究设计与样本

  • 单机构回顾性队列研究,纳入2010至2018年接受新辅助放化疗及R0食管切除术的食管腺癌患者537例,主要终点为淋巴结转移部位与无病生存的关联。

主要发现

  • 537例中193例(36%)术后病理存在淋巴结转移,其中153例(28%)为单站、32例(6.0%)为两站、8例(1.5%)为三站。
  • 多站阳性患者中,食管旁站阳性占93%,左胃站阳性占60%。
  • 校正临床因素的多变量Cox模型显示,阳性淋巴结站数增加与复发风险增加相关(HR 1.59,95%CI 1.35-1.84,P<.01)。
  • 隆突下站转移与复发风险增加相关(HR 2.78,95%CI 1.54-5.03,P<.01),食管旁站转移亦与复发风险增加相关(HR 2.0,95%CI 1.58-2.54,P<.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Little is known about the pattern of nodal metastases in patients with esophageal adenocarcinoma who have received neoadjuvant chemoradiation and undergone surgery. We sought to assess this pattern and evaluate its association with prognosis. METHODS: All patients with esophageal adenocarcinoma who underwent neoadjuvant chemoradiation and R0 esophagectomy between 2010 and 2018 at our institution were included (n = 537). The primary objective was to evaluate the association of sites of lymph node metastases with disease-free survival. The number of nodal stations and individual sites of nodal metastases were evaluated first in univariable then in separate multivariable Cox regression models adjusted for clinical factors. RESULTS: Of 537 patients, 193 (36%) had pathologic nodal metastases at the time of surgery; 153 (28%) had single-station disease, 32 (6.0%) had 2-station disease, and 8 (1.5%) had 3-station disease. The majority of patients with multiple positive nodal stations had positive nodes in the paraesophageal (93%) and/or left gastric stations (60%). Multivariable models controlling for clinical factors showed that an increasing number of positive nodal stations (hazard ratio, 1.59; 95% CI, 1.35-1.84; P < .01)-in particular, the subcarinal (hazard ratio, 2.78; 95% CI, 1.54-5.03; P < .01) and paraesophageal stations (hazard ratio, 2.0; 95% CI, 1.58-2.54; P < .01)-was associated with increased risk of recurrence. CONCLUSIONS: One-third of patients who have undergone R0 resection for esophageal adenocarcinoma following induction chemoradiation therapy have metastatic lymph nodes. An increasing number of nodal stations, particularly paraesophageal and subcarinal metastases, were associated with increased risk of recurrence.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Harrington CA, Carr RA, Hsu M, et al. Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2022. PMID: 35346491. doi:10.1016/j.jtcvs.2021.11.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。